Influence of intravascular molecular weight of hydroxyethyl starch on platelets

European Journal of Haematology

Volumn 56, Issue 3, 1996, Pages 168-172

  Treib, J ^a   Haass, A ^a   Pindur, G ^a   Treib, W ^a   Wenzel, E ^a   Schimrigk, K ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Hemodilution; Hydroxyethyl starch; Molecular weight; Platelet; Platelet volume

Indexed keywords

HETASTARCH;

ARTICLE; BLOOD VESSEL; CEREBROVASCULAR DISEASE; CLINICAL ARTICLE; DRUG BLOOD LEVEL; HEMODILUTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MOLECULAR WEIGHT; PRIORITY JOURNAL; THROMBOCYTE;

EID: 0029931794     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.1996.tb01337.x     Document Type: Article

References (25)

1. CULLY MD, LARSON CP, SILVERBERG GD. Hetastarch coagulopathy in a neurosurgical patient. Anesthesiology 1987: 66: 707-8.
2. DAMON L, ADAMS M, STRICKER RB, RIES C. Intracranial bleeding during treatment with hydroxyethyl starch. N Engl J Med 1987: 317: 964-965.
3. SYMINGTON BE. Hetastarch and bleeding complications. Ann Intern Med 1986: 105: 627-628.
4. LOCKWOOD DNJ, BULLEN C, MACHIN SJ. A severe coagulophathy following volume replacement with hydroxyethyl-starch in a Jehovah's Witness. Anaesthesia 1988: 43: 391-393.
5. HAASS A, STOLL M, TREIB J. Hemodilution in cerebral circulatory disturbances: indications, implementation, additional drug treatment and alternatives. In: KOSCIELNY J, KIESEWETTER H, JUNG F, HAASS A, eds. Hämodilution. New aspects in the management of circulatory blood flow. Improvement of macro- and microcirculation. Berlin-Heidelberg-New York: Springer, 1992: 53-114.
6. BOLDT J, KNOTHE C, ZICKMANN B, ANDRES P, DAPPER F, HEMPELMANN G. Influence of different intravascular volume therapies on platelet function in patients undergoing cardiopulmonary bypass. Anesth Analg 1993: 76: 1185-1190.
7. YOSHIDA M, MINAMI Y, KISHIKAWA T. A study of hydroxyethyl starch. Part III. Comparison of metabolic fates between 2-0-hydroxyethyl starch and 6-0-hydroxyethyl starch in rabbits. Starch/Stärke 1984; 36: 209-212.
8. HAASS A, TREIB W, TREIB J, PINDUR G, MIYASHITA C, WENZEL E. Dependence of haemorheological and haemostaseologic effects on the hydroxylation degree and mode of starch. Blut 1990; 60: 116.
9. HAASS A, TREIB J, STOLL M. Hemorheological parameters of hydroxyethyl starch 200/0,62 as a basis for hemodilution. Clin Hemorheol 1992: 12, Supp.1: 17-26.
10. FÖRSTER H, WICARKZYK C, DUDZIAK R. Bestimmung der Plasmaelimination von Hydroxyäthylstärke und von Dextran mittels verbesserter analytischer Methodik. Infusionstherapie 1981: 2: 88-94.
11. EIGNER W-D. Hydroxyethylstärke, Molmassenbestimmung von Hydroxyethylstärke in Elektrolytlösung nach Temperaturbelastung. Krankenhauspharmazie 1988: 9: 20-22.
12. SCHERER R, GIEBLER R, KAMPE S, Kox WJ. Effects of hypertonic saline hydroxyethyl starch solution on collagen-induced platelet aggregation and ATP secretion. Infusionsther Transfusionsmed 1994: 21: 310-314.
13. HIIPPALA S, LINKO K, MYLLYLÄ M, LALLA M, MÄKELÄINEN A. Albumin, HES 120 and Dextran 70 as adjuvans to red blood cell concentrates: a study on colloid osmotic pressure changes in vitro. Acta Anaesthesiol Scand 1991: 35: 654-659.
14. KEMONA H, ANDRZEJEWSKA A, PROKOPOWICZ J, NOWAK H, MANTUR M. Phagocytic activity of human blood platelets examined by electron microscopy. Folia Haematol 1986: 113: 696-702.
15. THREATTE GA. Usefulness of the mean platelet volume. Clin Lab Med 1993: 13: 937-950.
16. KRISTENSEN SD, MILNER PC, MARTIN JF. Bleeding time and platelet volume in acute myocardial infarction - a 2 year follow-up study. Thrombos Haemostas 1988: 59: 353-356.
17. ERNE P, WARDLE J, SANDERS K, LEWIS SM, MASERI A. Mean platelet volume and size distribution and their sensitivity to agonists in patients with coronary artery disease and congestive heart failure. Thrombos Haemostas 1988: 59: 259-263.
18. BESSMANN JD, GILMER PR, GARDNER FH. Use of mean platelet volume improves detection of platelet disorders. Blood Cells 1985: 11: 127-135.
19. LEVIN J, BESSMAN JD. The inverse relation between platelet volume and platelet number. J Lab Clin Med 1983: 101: 295-307.
20. THOMPSON CB, EATON KA, PRINCIOTTA SM, RUSHIN CA, VALERI CR. Size dependent platelet subpopulations: relationship of platelet volume to ultrastructure, enzymatic activity and function. Br J Haematol 1982: 50: 509-519.
21. ELDOR A, AVITZOUR M, OR R, HANNA R, PENCHAS S. Prediction of haemorrhagic diathesis in thrombocytopenia by mean platelet volume. Br Med J 1982: 285: 397-400.
22. STUMP DC, STRAUSS RG, HENRIKSEN RA, PETERSEN RE, SAUNDERS R. Effects of hydroxyethyl starch on blood coagulation, particularly factor VIII. Transfusion 1985: 25: 349-354.
23. STRAUSS RG, STANSFIELD C, HENRIKSEN RA, VILLHAUER PJ. Pentastarch may cause fewer effects on coagulation than hetastarch. Transfusion 1988: 28: 257-260.
24. PINDUR G, HAASS A, TREIB J, et al. Influence of hydroxyethyl starch on haemostatic and rheological parameters during treatment of cerebrovascular disease. Thrombos Haemostas 1989: 62: 586.
25. KUITUNEN A, HYNYNEN M, SALMENPERA M, et al. Hydroxyethyl starch as a prime for cardiopulmonary bypass: effects of two different solutions on haemostasis. Acta Anaesthesiol Scand 1993: 37: 652-658.